Assessment of pain improvement in rheumatoid arthritis patients treated with baricitinib, who were inadequate responders to methotrexate and tumor necrosis factor inhibitors

Những quyển sách tương tự

• Achieving pain control in rheumatoid arthritis with baricitinib or ddalimumab plus methotrexate: Results from the RA-BEAM Trial
  Bằng: Taylor, P, et al.
  Được phát hành: (2019)
• Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapy
  Bằng: Taylor, P, et al.
  Được phát hành: (2022)
• Improved patient-reported outcomes in patients with rheumatoid arthritis who failed adalimumab or placebo treatment and were rescued with baricitinib
  Bằng: Fautrel, B, et al.
  Được phát hành: (2017)
• Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate.
  Bằng: Keystone, E, et al.
  Được phát hành: (2015)
• Effect of baricitinib and adalimumab in reducing pain and improving function in patients with rheumatoid arthritis in low disease activity: exploratory analyses from RA-BEAM
  Bằng: Fautrel, B, et al.
  Được phát hành: (2019)